The role of cyclin E deregulation in breast tumorigenesis

细胞周期蛋白 E 失调在乳腺肿瘤发生中的作用

基本信息

  • 批准号:
    7679541
  • 负责人:
  • 金额:
    $ 15.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Breast cancer is the second most frequently occurring malignancy in U.S. women, and a more thorough understanding of its pathogenesis should enable the development of improved tools for detection, prognosis determination, and treatment. Overexpression of the cell cycle regulatory protein, cyclin E, is frequently observed in human breast tumors, and high cyclin E is proposed to be a marker of poor prognosis cancers. Whether deregulation of cyclin E contributes directly to breast tumorigenesis is unknown. The overall goals of the proposed experiments are to understand how deregulated cyclin E activity functions during mammary tumorigenesis and to identify the key cellular barriers against cyclin E-associated breast cancer. In addition to high cyclin E expression, reduced expression of the cyclin-dependent kinase inhibitor p27Kip1 has also been found to correlate with poor prognosis in breast cancers. Using three-dimensional mammary epithelial cultures, I found that cyclin E overexpression cooperates with decreased p27 expression to produce hyper-proliferative mammary epithelial structures in vitro. In Specific Aim 1, I will elucidate the basis for this cooperation. I recently developed a knockin mouse containing mutations at two major cyclin E phosphorylation sites regulating its binding to Fbw7/SCF ubiquitin ligase complex. Tissues from these animals contain markedly elevated cyclin E protein levels and kinase activity and are hyper-proliferative, including the mammary epithelia. Based on results of my preliminary studies, I hypothesize that the p27 and p53 tumor suppressors inhibit the oncogenicity of deregulated cyclin E. In experiments proposed in Aims 2 and 3, I will develop new animal models to understand how loss of normal p27 and p53 function, respectively, promotes cyclin E-associated mammary tumorigenesis. The overall career development goal of the proposed work is to enable me to begin a productive, independent research career focused on understanding critical steps in the molecular pathogenesis of breast cancer. I recently started my laboratory at the Northwestern University Feinberg School of Medicine, where I joined as Assistant Professor in the Department of Medicine, Hematology/Oncology Division. At Northwestern, a comprehensive mentoring program is in place to support the goals of this proposed research as well as my career development.
描述(由申请人提供):乳腺癌是美国女性中第二大最常见的恶性肿瘤,对其发病机制的更深入了解将有助于开发改进的检测、预后确定和治疗工具。细胞周期调节蛋白cyclin E在人类乳腺肿瘤中经常被观察到过表达,高cyclin E被认为是癌症预后不良的标志。撤消周期蛋白E是否直接导致乳腺肿瘤发生尚不清楚。拟议实验的总体目标是了解在乳腺肿瘤发生过程中细胞周期蛋白E活性的失调是如何起作用的,并确定细胞周期蛋白E相关乳腺癌的关键细胞屏障。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander C Minella其他文献

Alexander C Minella的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander C Minella', 18)}}的其他基金

Cyclin E Regulation in Normal and Neoplastic Hematopoiesis
正常和肿瘤造血中的细胞周期蛋白 E 调节
  • 批准号:
    8514050
  • 财政年份:
    2010
  • 资助金额:
    $ 15.43万
  • 项目类别:
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis
正常和肿瘤造血中的细胞周期蛋白 E 调节
  • 批准号:
    8119546
  • 财政年份:
    2010
  • 资助金额:
    $ 15.43万
  • 项目类别:
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis
正常和肿瘤造血中的细胞周期蛋白 E 调节
  • 批准号:
    8872315
  • 财政年份:
    2010
  • 资助金额:
    $ 15.43万
  • 项目类别:
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis
正常和肿瘤造血中的细胞周期蛋白 E 调节
  • 批准号:
    7984791
  • 财政年份:
    2010
  • 资助金额:
    $ 15.43万
  • 项目类别:
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis
正常和肿瘤造血中的细胞周期蛋白 E 调节
  • 批准号:
    8309057
  • 财政年份:
    2010
  • 资助金额:
    $ 15.43万
  • 项目类别:
The role of cyclin E deregulation in breast tumorigenesis
细胞周期蛋白 E 失调在乳腺肿瘤发生中的作用
  • 批准号:
    7884539
  • 财政年份:
    2008
  • 资助金额:
    $ 15.43万
  • 项目类别:
The role of cyclin E deregulation in breast tumorigenesis
细胞周期蛋白 E 失调在乳腺肿瘤发生中的作用
  • 批准号:
    7529227
  • 财政年份:
    2008
  • 资助金额:
    $ 15.43万
  • 项目类别:
Mechanisms of cyclin E associated tumorigenesis
细胞周期蛋白E相关肿瘤发生机制
  • 批准号:
    6669577
  • 财政年份:
    2003
  • 资助金额:
    $ 15.43万
  • 项目类别:
Mechanisms of cyclin E associated tumorigenesis
细胞周期蛋白E相关肿瘤发生机制
  • 批准号:
    7263987
  • 财政年份:
    2003
  • 资助金额:
    $ 15.43万
  • 项目类别:
Mechanisms of cyclin E associated tumorigenesis
细胞周期蛋白E相关肿瘤发生机制
  • 批准号:
    6917179
  • 财政年份:
    2003
  • 资助金额:
    $ 15.43万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 15.43万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 15.43万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 15.43万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 15.43万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 15.43万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 15.43万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 15.43万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 15.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 15.43万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 15.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了